Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bally's (BALY) Cash & Equivalents (2018 - 2025)

Historic Cash & Equivalents for Bally's (BALY) over the last 8 years, with Q3 2025 value amounting to $160.7 million.

  • Bally's' Cash & Equivalents fell 1585.86% to $160.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.7 million, marking a year-over-year decrease of 1585.86%. This contributed to the annual value of $171.2 million for FY2024, which is 492.6% up from last year.
  • Bally's' Cash & Equivalents amounted to $160.7 million in Q3 2025, which was down 1585.86% from $174.6 million recorded in Q2 2025.
  • In the past 5 years, Bally's' Cash & Equivalents registered a high of $344.3 million during Q1 2023, and its lowest value of $151.7 million during Q1 2021.
  • For the 5-year period, Bally's' Cash & Equivalents averaged around $185.9 million, with its median value being $174.6 million (2025).
  • As far as peak fluctuations go, Bally's' Cash & Equivalents plummeted by 5805.95% in 2021, and later skyrocketed by 11412.64% in 2023.
  • Bally's' Cash & Equivalents (Quarter) stood at $206.2 million in 2021, then increased by 3.07% to $212.5 million in 2022, then decreased by 23.21% to $163.2 million in 2023, then grew by 4.93% to $171.2 million in 2024, then dropped by 6.16% to $160.7 million in 2025.
  • Its Cash & Equivalents was $160.7 million in Q3 2025, compared to $174.6 million in Q2 2025 and $209.7 million in Q1 2025.